Organization of the mouse RNA-specific adenosine deaminase Adar1 gene 5′-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon

被引:43
作者
George, Cyril X. [1 ]
Das, Sonali [1 ]
Samuel, Charles E. [1 ,2 ]
机构
[1] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA
[2] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA
关键词
Interferon; Signal Transducers and Activators of Transcription (STAT); Adenosine Deaminase Acting on RNA (ADAR);
D O I
10.1016/j.virol.2008.07.029
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The p150 form of the RNA-specific adenosine deaminase ADAR1 is interferon-inducible and catalyzes A-to-I editing of viral and cellular RNAs. We have characterized mouse genomic clones containing the promoter regions required for Adar1 gene transcription and analyzed interferon induction of the p150 protein using mutant mouse cell lines. Transient transfection analyses using reporter constructs led to the identification of three promoters, one interferon-inducible (P-A) and two constitutively active (P-B and P-C). The TATA-less P-A promoter, characterized by the presence of a consensus ISRE element and a PKR kinase KCS-like element, directed interferon-inducible reporter expression in rodent and human cells. Interferon induction of p150 was impaired in mouse cells deficient in IFNAR receptor, JAK1 kinase or STAT2 but not STAT1. Whereas Adar1 gene organization involving multiple promoters and alternative exon I structures was highly preserved, sequences of the promoters and exon I structures were not well conserved between human and mouse. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:338 / 343
页数:6
相关论文
共 53 条
[1]   The crystal structure of the Zβ domain of the RNA-editing enzyme ADAR1 reveals distinct conserved surfaces among Z-domains [J].
Athanasiadis, A ;
Placido, D ;
Maas, S ;
Brown, BA ;
Lowenhaupt, K ;
Rich, A .
JOURNAL OF MOLECULAR BIOLOGY, 2005, 351 (03) :496-507
[2]  
Bass BL, 1997, RNA, V3, P947
[3]   Interferons at age 50: past, current and future impact on biomedicine [J].
Borden, Ernest C. ;
Sen, Ganes C. ;
Uze, Gilles ;
Silverman, Robert H. ;
Ransohoff, Richard M. ;
Foster, Graham R. ;
Stark, George R. .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (12) :975-990
[4]   Transcription factor Sp3 is essential for post-natal survival and late tooth development [J].
Bouwman, P ;
Göllner, H ;
Elsässer, HP ;
Eckhoff, G ;
Karis, A ;
Grosveld, F ;
Philipsen, S ;
Suske, G .
EMBO JOURNAL, 2000, 19 (04) :655-661
[5]   BIASED (A-]I) HYPERMUTATION OF ANIMAL RNA VIRUS GENOMES [J].
CATTANEO, R .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1994, 4 (06) :895-900
[6]   BIASED HYPERMUTATION AND OTHER GENETIC CHANGES IN DEFECTIVE MEASLES VIRUSES IN HUMAN-BRAIN INFECTIONS [J].
CATTANEO, R ;
SCHMID, A ;
ESCHLE, D ;
BACZKO, K ;
TERMEULEN, V ;
BILLETER, MA .
CELL, 1988, 55 (02) :255-265
[7]   Activation of the RNA-dependent protein kinase PKR promoter in the absence of interferon is dependent upon sp proteins [J].
Das, S ;
Ward, SV ;
Tacke, RS ;
Suske, G ;
Samuel, CE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (06) :3244-3253
[8]   RNA editing of the human herpesvirus 8 kaposin transcript eliminates its transforming activity and is induced during lytic replication [J].
Gandy, Sharon Z. ;
Linnstaedt, Sarah D. ;
Muralidhar, Sumitra ;
Cashman, Kathleen A. ;
Rosenthal, Leonard J. ;
Casey, John L. .
JOURNAL OF VIROLOGY, 2007, 81 (24) :13544-13551
[9]   Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible [J].
George, CX ;
Samuel, CE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4621-4626
[10]   Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing [J].
George, CX ;
Wagner, MV ;
Samuel, CE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (15) :15020-15028